Pfizer To Seek Second Booster For Those Over Age 65

The Washington Post reports:

Pharmaceutical giant Pfizer and its partner, BioNTech, will seek emergency authorization for a second booster shot of their coronavirus vaccine for people 65 and older, an effort to bolster waning immunity that occurs several months after the first booster.

The submission to the Food and Drug Administration, anticipated as soon as Tuesday, is expected to include “real world data” collected in Israel, one of the few countries that has authorized a second booster for older people.

The decision from the FDA could come relatively quickly, especially if officials conclude the data is straightforward and does not have to be reviewed by a panel of outside vaccine experts.

Read the full article.

Scoop: Pfizer will seek authorization of second coronavirus booster shot for people 65 and older, an effort to bolster waning immunity that occurs several months after the first booster

Story w/ @lauriemcginley2 + @Carolynyjohnson https://t.co/Nbk8cyEuOn

— Tyler Pager (@tylerpager) March 15, 2022